International normalised ratio stability in patients aged 80 years and over taking warfarin for non-valvular atrial fibrillation

Wolf, 1991, Atrial fibrillation as an independent risk factor for stroke: the Framingham Study, Stroke, 22, 983, 10.1161/01.STR.22.8.983 January, 2014, 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary, J Am Coll Cardiol, 64, 2246, 10.1016/j.jacc.2014.03.021 Camm, 2012, 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation—developed with the special contribution of the European Heart Rhythm Association, Europace, 14, 1385 Hart, 2007, Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation, Ann Intern Med, 146, 857, 10.7326/0003-4819-146-12-200706190-00007 Pisters, 2010, A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey, Chest, 138, 1093, 10.1378/chest.10-0134 Hutten, 1999, Safety of treatment with oral anticoagulants in the elderly. A systematic review, Drugs Aging, 14, 303, 10.2165/00002512-199914040-00005 De Caterina, 2012, New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper, J Am Coll Cardiol, 59, 1413, 10.1016/j.jacc.2012.02.008 White, 2007, Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V, Arch Intern Med, 67, 239, 10.1001/archinte.167.3.239 Moss, 2015, Management of anticoagulation in patients with atrial fibrillation, JAMA, 314, 291, 10.1001/jama.2015.3088 Reynolds, 2004, Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis, Chest, 126, 1938, 10.1378/chest.126.6.1938 Morgan, 2009, Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control, Thromb Res, 124, 37, 10.1016/j.thromres.2008.09.016 Connolly, 2008, Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range, Circulation, 118, 2029, 10.1161/CIRCULATIONAHA.107.750000 National Institute for Health and Care Excellence, 2014 Lefebvre, 2016, The effect of bleeding risk and frailty status on anticoagulation patterns in octogenarians with atrial fibrillation: the FRAIL-AF study, Can J Cardiol, 32, 169, 10.1016/j.cjca.2015.05.012 Banerjee, 2014, Prior history of falls and risk of outcomes in atrial fibrillation: the Loire Valley Atrial Fibrillation Project, Am J Med, 127, 972, 10.1016/j.amjmed.2014.05.035 Hallinen, 2014, Warfarin treatment among Finnish patients with atrial fibrillation: retrospective registry study based on primary healthcare data, BMJ Open, 4, e004071, 10.1136/bmjopen-2013-004071 Patel, 2011, Rivaroxaban versus warfarin in nonvalvular atrial fibrillation, N Engl J Med, 365, 883, 10.1056/NEJMoa1009638 Jones, 2005, Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population, Heart, 91, 472, 10.1136/hrt.2004.042465 Garcia, 2005, Warfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly population, Chest, 127, 2049, 10.1378/chest.127.6.2049 Andreotti, 2015, Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis, Eur Heart J, 36, 3238 Eriksson, 2011, Novel oral factor Xa and thrombin inhibitors in the management of thromboembolism, Annu Rev Med, 62, 41, 10.1146/annurev-med-062209-095159 Granger, 2011, Apixaban versus warfarin in patients with atrial fibrillation, N Engl J Med, 365, 981, 10.1056/NEJMoa1107039 Connolly, 2009, Dabigatran versus warfarin in patients with atrial fibrillation, N Engl J Med, 361, 1139, 10.1056/NEJMoa0905561 Huisman, 2012, Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: resolving uncertainties in routine practice, Thromb Haemost, 107, 838, 10.1160/TH11-10-0718 Hylek, 1996, An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation, N Engl J Med, 335, 540, 10.1056/NEJM199608223350802 Pengo, 2011, Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA), Thromb Haemost, 106, 868, 10.1160/TH11-05-0358 Schmitt, 2003, Quality assessment of anticoagulation dose management: comparative evaluation of measures of time-in-therapeutic range, J Thromb Thrombolysis, 15, 213, 10.1023/B:THRO.0000011377.78585.63 Erkens, 2012, Benchmark for time in therapeutic range in venous thromboembolism: a systematic review and meta-analysis, PLoS ONE, 7, 10.1371/journal.pone.0042269